Related Experiment Videos
Risk of Clostridium difficile Infection in Hematology-Oncology Patients Colonized With Toxigenic C. difficile
Cara M Cannon1, Jackson S Musuuza2, Anna K Barker1
11Department of Population Health Sciences,University of Wisconsin School of Medicine and Public Health,Madison,Wisconsin.
Infection Control and Hospital Epidemiology
|April 12, 2017
Abstract:
The prevalence of colonization with toxigenic Clostridium difficile among patients with hematological malignancies and/or bone marrow transplant at admission to a 566-bed academic medical care center was 9.3%, and 13.3% of colonized patients developed symptomatic disease during hospitalization. This population may benefit from targeted C. difficile infection control interventions. Infect Control Hosp Epidemiol 2017;38:718-720.